Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-β signaling

Taegun Seo, Junsoo Park, Joonho Choe

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Kaposi's sarcoma-associated herpesvirus, also called human herpesvirus 8, has been implicated in the pathogenesis of Kaposi's sarcoma, body cavity-based primary effusion lymphoma, and some forms of multicentric Castleman's disease. The Kaposi's sarcoma-associated herpesvirus open reading frame K9 encodes viral IFN regulatory factor 1 (vIRF1), which functions as a repressor of IFN-mediated signal transduction. vIRF1 expression in NIH 3T3 cells leads to transformation and consequently induces malignant fibrosarcoma in nude mice, suggesting that vIRF1 is a strong oncoprotein. Here, we show that vIRF1 inhibited transforming growth factor-β (TGF-β) signaling via its targeting of Smad proteins. vIRF1 suppressed TGF-β-mediated transcription and growth arrest. vIRF1 directly interacted with both Smad3 and Smad4, resulting in inhibition of their transactivation activity. Studies using vIRF1 deletion mutants showed that the central region of vIRF1 was required for vIRF1 association with Smad3 and Smad4 and that this region was also important for inhibition of TGF-β signaling. In addition, we found that vIRF1 interfered with Smad3-Smad4 complex formation and inhibited Smad3/Smad4 complexes from binding to DNA. These results indicate that vIRF1 inhibits TGF-β signaling via interaction with Smads. In addition, the data indicate the TGF-β pathway is an important target for viral oncoproteins.

Original languageEnglish
Pages (from-to)1738-1747
Number of pages10
JournalCancer Research
Volume65
Issue number5
DOIs
Publication statusPublished - 2005 Mar 1

Fingerprint

Human Herpesvirus 8
Transforming Growth Factors
Oncogene Proteins
Primary Effusion Lymphoma
Smad Proteins
NIH 3T3 Cells
Fibrosarcoma
Kaposi's Sarcoma
Nude Mice
Transcriptional Activation
Open Reading Frames
Signal Transduction
DNA
Growth

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{04cf160753a54adaa0560249e97ef354,
title = "Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-β signaling",
abstract = "Kaposi's sarcoma-associated herpesvirus, also called human herpesvirus 8, has been implicated in the pathogenesis of Kaposi's sarcoma, body cavity-based primary effusion lymphoma, and some forms of multicentric Castleman's disease. The Kaposi's sarcoma-associated herpesvirus open reading frame K9 encodes viral IFN regulatory factor 1 (vIRF1), which functions as a repressor of IFN-mediated signal transduction. vIRF1 expression in NIH 3T3 cells leads to transformation and consequently induces malignant fibrosarcoma in nude mice, suggesting that vIRF1 is a strong oncoprotein. Here, we show that vIRF1 inhibited transforming growth factor-β (TGF-β) signaling via its targeting of Smad proteins. vIRF1 suppressed TGF-β-mediated transcription and growth arrest. vIRF1 directly interacted with both Smad3 and Smad4, resulting in inhibition of their transactivation activity. Studies using vIRF1 deletion mutants showed that the central region of vIRF1 was required for vIRF1 association with Smad3 and Smad4 and that this region was also important for inhibition of TGF-β signaling. In addition, we found that vIRF1 interfered with Smad3-Smad4 complex formation and inhibited Smad3/Smad4 complexes from binding to DNA. These results indicate that vIRF1 inhibits TGF-β signaling via interaction with Smads. In addition, the data indicate the TGF-β pathway is an important target for viral oncoproteins.",
author = "Taegun Seo and Junsoo Park and Joonho Choe",
year = "2005",
month = "3",
day = "1",
doi = "10.1158/0008-5472.CAN-04-2374",
language = "English",
volume = "65",
pages = "1738--1747",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-β signaling. / Seo, Taegun; Park, Junsoo; Choe, Joonho.

In: Cancer Research, Vol. 65, No. 5, 01.03.2005, p. 1738-1747.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-β signaling

AU - Seo, Taegun

AU - Park, Junsoo

AU - Choe, Joonho

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Kaposi's sarcoma-associated herpesvirus, also called human herpesvirus 8, has been implicated in the pathogenesis of Kaposi's sarcoma, body cavity-based primary effusion lymphoma, and some forms of multicentric Castleman's disease. The Kaposi's sarcoma-associated herpesvirus open reading frame K9 encodes viral IFN regulatory factor 1 (vIRF1), which functions as a repressor of IFN-mediated signal transduction. vIRF1 expression in NIH 3T3 cells leads to transformation and consequently induces malignant fibrosarcoma in nude mice, suggesting that vIRF1 is a strong oncoprotein. Here, we show that vIRF1 inhibited transforming growth factor-β (TGF-β) signaling via its targeting of Smad proteins. vIRF1 suppressed TGF-β-mediated transcription and growth arrest. vIRF1 directly interacted with both Smad3 and Smad4, resulting in inhibition of their transactivation activity. Studies using vIRF1 deletion mutants showed that the central region of vIRF1 was required for vIRF1 association with Smad3 and Smad4 and that this region was also important for inhibition of TGF-β signaling. In addition, we found that vIRF1 interfered with Smad3-Smad4 complex formation and inhibited Smad3/Smad4 complexes from binding to DNA. These results indicate that vIRF1 inhibits TGF-β signaling via interaction with Smads. In addition, the data indicate the TGF-β pathway is an important target for viral oncoproteins.

AB - Kaposi's sarcoma-associated herpesvirus, also called human herpesvirus 8, has been implicated in the pathogenesis of Kaposi's sarcoma, body cavity-based primary effusion lymphoma, and some forms of multicentric Castleman's disease. The Kaposi's sarcoma-associated herpesvirus open reading frame K9 encodes viral IFN regulatory factor 1 (vIRF1), which functions as a repressor of IFN-mediated signal transduction. vIRF1 expression in NIH 3T3 cells leads to transformation and consequently induces malignant fibrosarcoma in nude mice, suggesting that vIRF1 is a strong oncoprotein. Here, we show that vIRF1 inhibited transforming growth factor-β (TGF-β) signaling via its targeting of Smad proteins. vIRF1 suppressed TGF-β-mediated transcription and growth arrest. vIRF1 directly interacted with both Smad3 and Smad4, resulting in inhibition of their transactivation activity. Studies using vIRF1 deletion mutants showed that the central region of vIRF1 was required for vIRF1 association with Smad3 and Smad4 and that this region was also important for inhibition of TGF-β signaling. In addition, we found that vIRF1 interfered with Smad3-Smad4 complex formation and inhibited Smad3/Smad4 complexes from binding to DNA. These results indicate that vIRF1 inhibits TGF-β signaling via interaction with Smads. In addition, the data indicate the TGF-β pathway is an important target for viral oncoproteins.

UR - http://www.scopus.com/inward/record.url?scp=16444366149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16444366149&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-2374

DO - 10.1158/0008-5472.CAN-04-2374

M3 - Article

C2 - 15753369

AN - SCOPUS:16444366149

VL - 65

SP - 1738

EP - 1747

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 5

ER -